Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (7) : cancer treatment

Reclaiming Hope: Gilead's Fight Against Triple-Negative Breast Cancer

Reclaiming Hope: Gilead's Fight Against Triple-Negative Breast Cancer
06/09/2025 | Companies
When Emma received a diagnosis of triple-negative breast cancer, she refused to let it dictate her future. Cancer can take away so much, but at Gilead, we're striving to reclaim what it steals. Our commitment to redefining cancer treatment continues, and we’re excited to present our latest research...
ASCO25, cancer care, cancer innovation, cancer research, cancer resilience, cancer treatment, Gilead, medical breakthroughs, oncology, patient stories, research advancement, triple-negative breast cancer

Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025

Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
05/29/2025 | Companies
GileadNews: In partnership with Kite Pharma, we are excited to share groundbreaking cancer research at this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) conferences. Our contribution includes over 20 abstracts, featuring late-breaking findings in...
American Society of Clinical Oncology, ASCO, cancer research, cancer treatment, CAR T-cell therapy, clinical trials, collaborative research, EHA, European Hematology Association, GileadNews, hematology, innovative therapies, investigational therapy, Kite Pharma, metastatic triple-negative breast cancer, oncology, Phase 2 results, recurrent glioblastoma, refractory multiple myeloma, relapsed multiple myeloma

Innovative Cancer Care: Digital Tools & Research Backed by Gilead

Innovative Cancer Care: Digital Tools & Research Backed by Gilead
04/17/2025 | Companies
Dr. Maria Alice Franzoi, a medical oncologist with experience practicing in three different countries, brings a deep understanding of diverse healthcare systems. She is particularly passionate about exploring patient-centered care approaches and the integration of cutting-edge digital health...
breast cancer, cancer research, cancer signaling, cancer treatment, clinical programs, decentralized care, digital health, early-career researchers, epigenetic therapy, Gilead Sciences, healthcare innovation, healthcare technology, immune system, medical oncology, oncology funding, oncoproteins, ovarian cancer, patient-centered care, PIK3CA mutations, primary care, proactive care, remote monitoring, Research Scholars Program, scientific research, tumor research

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma
04/07/2025 | Companies
We're committed to advancing innovation in virology, oncology, and immunology, with a strong emphasis on supporting groundbreaking science that transforms cancer treatment. In the newest episode of The Centrifuge Sessions, Dr. Samuel Haile, Director of Cell Biology at Kite Pharma, shares insights...
biotechnology, cancer innovation, cancer research, cancer treatment, cell biology, cell therapy, immunology, innovative medicine, Kite Pharma, oncology, patient hope, Samuel Haile, The Centrifuge Sessions, virology

Teva & Global HOPE: Expanding Pediatric Cancer Care Worldwide

Teva & Global HOPE: Expanding Pediatric Cancer Care Worldwide
03/10/2025 | Companies
In wealthier nations, over 80% of children diagnosed with cancer survive. Unfortunately, in some low- and middle-income countries, this survival rate drops significantly to just 20%. During a UN General Assembly meeting in 2018, Dr. David G. Poplack, the founding director of Global HOPE...
cancer care, cancer treatment, child cancer survival, global health, Global HOPE, healthcare access, healthcare training, low-income countries, medical partnerships, medicine donations, oncology, pediatric cancer, pediatric oncology, pharmaceutical support, Teva

Revolutionizing Blood Cancer Diagnosis with Whole-Genome Sequencing

Revolutionizing Blood Cancer Diagnosis with Whole-Genome Sequencing
12/16/2024 | Companies
The Leukemia & Lymphoma Society projects that by the end of 2024, approximately 187,740 Americans will be diagnosed with blood cancer, equating to about one new case every three minutes. This statistic highlights the complexity of diagnosing and treating these conditions. Traditional diagnostic...
AML, bioinformatics, blood cancer, cancer prognosis, cancer treatment, copy number alterations, diagnostic technology, genetic testing, genomic profiling, healthcare innovation, Illumina, leukemia, lymphoma, medical research, mutational analysis, precision medicine, risk stratification, sequencing technology, structural variants, tumor analysis, whole-genome sequencing

Brazil receives its first cancer care clinic

Brazil receives its first cancer care clinic
12/08/2022 | Companies
Brazil receives its first cancer treatment facility. For far too long, cancer patients in Lesotho believed that life-changing cancer treatment was out of reach. There were no oncology clinics in their landlocked country, which was surrounded by South Africa and surrounded by steep mountains. Those...
Bloemfontein, Brazil, Bristol Myers Squibb Foundation, cancer patients, cancer treatment, chemotherapy, Dr. Pearl Ntekhe, healthcare providers, India, Maseru, oncology clinics, oncology nurses, pharmacists, Senkatana Oncology Clinic, South Africa, South patients, treatments


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com